Showing 15 posts of 345 posts found.


MSD discontinues development of COVID-19 vaccines

January 26, 2021
Manufacturing and Production MSD, Merck

Merck, known as MSD outside of the US and Canada, has announced that the company is discontinuing development of its …


Pfizer and Merck KGaA secure CHMP recommendation for Bavencio in Europe for first-line maintenance of urothelial carcinoma

December 14, 2020
Sales and Marketing Bavencio, CHMP, EMA, Merck, Pfizer, pharma, urothelial carcinoma

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given its recommendation for …


Bavencio/axitinib combo approved for NHS Scotland in advanced renal cell carcinoma

October 13, 2020
Manufacturing and Production, Sales and Marketing Merck, NHS, Pfizer, SMC

The Scottish Medicines Consortium (SMC) has given the go-ahead to Merck KGaA and Pfizer’s combination of their PD-L1 inhibitor immunotherapy …


MHRA gives OK to Bavencio for first-line maintenance of advanced bladder cancer via the Early Access to Medicines Scheme

September 3, 2020
Sales and Marketing Bavencio, MHRA, Merck, Pfizer, UK, eams, pharma

It has been revealed that Bavencio (avelumab), jointly developed by Merck KGaA and Pfizer, has been approved by the UK …


Bavencio+Inylta combo approved or Cancer Drugs Fund in advanced renal cell carcinoma

July 31, 2020
Medical Communications, Sales and Marketing Merck, NICE, Pfizer, pharma

NICE has revealed that a combination of Merck KGaA’s Bavencio (avelumab) and Pfizer’s Inlyta (axitinib) will be made available as …

FDA approves Pfizer and Merck KGaA’s Bavencio for maintenance of advanced bladder cancer

July 1, 2020
Research and Development, Sales and Marketing Bavencio FDA, EMD Serono, Merck, Pfier

The FDA has moved to approve Bavencio (avelumab), developed by Pfizer and EMD Serono, the biopharma arm of Merck KGaA, …


Merck, Novartis and Allergan to raise US drug prices, following most of drug industry

January 6, 2020
Manufacturing and Production Allgeran, Big Pharma, Merck, Novartis, drug, drug prices

Following most of the large pharmaceutical companies, Merck, Novartis and Allergan have chosen to raise their drug prices. Novartis is …

FDA approves Merck & Co’s Ebola vaccine

December 20, 2019
Medical Communications Ebola, Ebola Drug, Ebola West Africa, Ebola vaccine, Merck

The FDA has approved Merck & Co’s Ebola vaccine, Ervebo. This marks the first time they have approved a vaccine …


FDA advisory panel back Merck & Co.’s Keytruda treatment for bladder cancer

December 18, 2019
Research and Development FDA, Merck, Merck and Co, NHS, NICE, keytruda

An FDA advisory committee voted 9 to 4 in favour of recommending Merk and Co’s Keytruda (pembrolizumab) for treatment in …


FDA advisory committee approves the use of Lynparza in pancreatic cancer

December 18, 2019
Research and Development AstraZeneca, Cancer, Merck, Pancreatic cancer, lynparza

The FDA’s Oncologic Drugs Advisory Committee (ODAC) has recommended the approval of AstraZeneca and Merck’s Lynparza (olaparib) to treat pancreatic …


MSD teams up with Harvard University to discover novel immune system pathways to fight cancer

August 13, 2019
Manufacturing and Production, Research and Development Cancer, Harvard, MSD, Merck, immuno-oncology, oncology, pharma

A new partnership between MSD and Harvard University hopes to combine the expertise of both parties to carve a path …


Drugmakers sue Trump over prices in TV ads

June 17, 2019
Sales and Marketing Amgen, Eli Lilly, HHS, MSD, Merck, Trump, pharma

Amgen, Eli Lilly and MSD have sued the Trump administration to try and block measures to force pharma companies to …


FDA ask MSD to join blockchain supply chain network

June 14, 2019
Medical Communications FDA, MSD, Merck, blockchain, supply chain

The FDA has asked MSD to join a shared permission blockchain network to help track and trace prescription medicines and …


FDA approves new indication for MSD’s Zerbaxa

June 5, 2019
Research and Development Merck, Zerbaxa, bacterial infection, pharma

The FDA has approved US firm Merck’s Zerbaxa (ceftolozane and tazobactam) for adults with hospital-acquired bacterial pneumonia and ventilator-associated bacterial …


Longest follow up trial of Merck’s Keytruda sets new standard for five year survival in lung cancer

June 3, 2019
Sales and Marketing KEYNOTE, MSD, Merck, keytruda, lung cancer

Nearly a quarter of previously untreated lung cancer patients who took Keytruda (Pembrolizumab) were alive after five years, according to …

Latest content